Vijaya Diagnostic Centre Limited has appointed Narasimha Raju K A as Chief Financial Officer, effective July 9, 2026, signaling a strategic move to reinforce financial leadership at a time of growth and expansion for the diagnostics specialist. The board-approved appointment marks a notable return, as Raju previously served as CFO of Vijaya from 2021 to 2025 before taking on senior roles elsewhere.
A Chartered Accountant with more than two decades of experience, Raju brings a track record spanning corporate governance, financial reporting, and strategic capital management. His career includes a formative stint with S R Batliboi & Co (an affiliate of Ernst & Young) and governance-driven leadership across healthcare, diagnostics, renewable energy, and real estate sectors. He has steered high-impact initiatives such as IPOs, investor relations, mergers and acquisitions, restructurings, and compliance for both listed and private equity-backed entities, including the company’s own IPO during the COVID-19 period.
Raju’s profile underscores a blend of financial rigor and strategic execution, with expertise in investor relations, MIS, budgeting, risk management, and cross-border transactions. Notably, he also led regulatory and governance frameworks to align with board and audit committee expectations, while focusing on strengthening financial controls and disclosures. Before rejoining Vijaya, he served as CFO of Yashoda Group of Hospitals, highlighting his continued leadership in complex, regulated environments.
The appointment is read as Vijaya’s continued commitment to robust financial management and governance as it pursues long-term objectives. With Raju at the helm of finance, the company aims to reinforce capital discipline, strategic financing, and stakeholder confidence during a pivotal phase of growth.